Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.66 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.66 |
| ▸ | HTR2B | P41595 | 1/20 | 0.66 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.66 |
| ▸ | PARP1 | P09874 | 2/20 | 0.57 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.55 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7114649 | 0.91 | LMNA (0.69) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL1892934 | 0.87 | KMT2A (0.64) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL11547493 | 0.85 | KDM4E (0.66) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL7325672 | 0.85 | PARP1 (0.60) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL9723275 | 0.85 | ALDH1A1 (0.55) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL28344533 | 0.84 | KMT2A (0.49) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL14157583 | 0.84 | KMT2A (0.69) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL73449 | 0.84 | KDM4E (0.69) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL3352936 | 0.84 | LMNA (0.79) | KMT2AMEN1KDM4ELMNAMAPT | |
| SCHEMBL8042223 | 0.84 | KMT2A (0.64) | KMT2AMEN1KDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467968-A1 | N-(4-SUBSTITUTED PHENYL)-ANTHRANILIC ACID HYDROXAMATE ESTERS | Warner-Lambert Company LLC (US) | 2004-10-20 | — | — | EP | claimed |
| WO-2003062191-A1 | N-(4-SUBSTITUTED PHENYL)-ANTHRANILIC ACID HYDROXAMATE ESTERS | WARNER-LAMBERT COMPANY LLC (US) | 2003-07-31 | — | — | WO | claimed |
| US-20240382457-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | NOVARTIS PHARMA AG (CH) | 2024-11-21 | — | — | US | disclosed |
| US-12083101-B2 | Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors | NOVARTIS AG (CH) | 2024-09-10 | — | — | US | disclosed |
| US-12011444-B2 | N-substituted indole derivatives as PGE2 receptor modulators | IDORSIA PHARMACEUTICALS LTD (CH) | 2024-06-18 | — | — | US | disclosed |
| WO-2024027795-A1 | ANTIBODY-DRUG CONJUGATE CONTAINING MYC PROTEIN DEGRADATION AGENT BIOACTIVE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 苏州开拓药业股份有限公司 | 2024-02-08 | — | — | WO | disclosed |
| EP-4121421-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | Novartis AG (CH) | 2023-01-25 | — | — | EP | disclosed |
| CN-113817152-B | Flame-retardant anti-dripping copolyester based on high-temperature self-crosslinking and preparation method and application thereof | 四川大学 | 2022-11-11 | — | — | CN | disclosed |
| US-20220175775-A1 | N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2022-06-09 | — | — | US | disclosed |
| US-11241431-B2 | N-substituted indole derivatives as PGE2 receptor modulators | IDORSIA PHARMACEUTICALS LTD (CH) | 2022-02-08 | — | — | US | disclosed |
| CN-113817152-A | Flame-retardant anti-dripping copolyester based on high-temperature self-crosslinking and preparation method and application thereof | 四川大学 | 2021-12-21 | — | — | CN | disclosed |
| EP-2164327-A2 | RADIOLABELLED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY (US) | 2010-03-24 | — | — | EP | disclosed |
| US-7659400-B2 | Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging | WASHINGTON UNIVERSITY (US) | 2010-02-09 | — | — | US | disclosed |
| WO-2009025914-A2 | RADIOLABELLED FLUOROBENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY (US) | 2009-02-26 | — | — | WO | disclosed |
| US-20080107599-A1 | RADIOLABELLED BENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | WASHINGTON UNIVERSITY OF ST. LOUIS | 2008-05-08 | — | — | US | disclosed |
| EP-1467968-A1 | N-(4-SUBSTITUTED PHENYL)-ANTHRANILIC ACID HYDROXAMATE ESTERS | Warner-Lambert Company LLC (US) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003062191-A1 | N-(4-SUBSTITUTED PHENYL)-ANTHRANILIC ACID HYDROXAMATE ESTERS | WARNER-LAMBERT COMPANY LLC (US) | 2003-07-31 | — | — | WO | disclosed |
| WO-2001064641-A1 | HYDROXYETHOXYBENZAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2001-09-07 | — | — | WO | disclosed |
| WO-2001036385-A1 | HYDROXYETHOXYBENZAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2001-05-25 | — | — | WO | disclosed |
| CN-1128025-A | Benzoxazinones and benzothiazinones having therapeutic activity | ITALFARMACO SPA (IT) | 1996-07-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107599-A1 | RADIOLABELLED BENZAMIDE ANALOGUES, THEIR SYNTHESIS AND USE IN DIAGNOSTIC IMAGING | TMEM97, SIGMAR1, SFN | KMT2A 2552/4885MEN1 1517/4885KDM4E 4331/4885 |
| US-12083101-B2 | Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors | YAP1, TEAD3, TEAD2 | KMT2A 1716/4885MEN1 3953/4885KDM4E 1512/4885 |
| US-20240382457-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | YAP1, TEAD3, TEAD2 | KMT2A 1716/4885MEN1 3953/4885KDM4E 1512/4885 |
| US-20220175775-A1 | N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS | PTGER1, PTGER4, PTGER2 | KMT2A 2262/4885MEN1 2595/4885KDM4E 2755/4885 |
| US-12011444-B2 | N-substituted indole derivatives as PGE2 receptor modulators | PTGER1, PTGER4, PTGER2 | KMT2A 2262/4885MEN1 2595/4885KDM4E 2755/4885 |
| US-11241431-B2 | N-substituted indole derivatives as PGE2 receptor modulators | PTGER1, PTGER4, PTGER2 | KMT2A 2262/4885MEN1 2595/4885KDM4E 2755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.